100 related articles for article (PubMed ID: 1699190)
1. Persistence of chromosomal aberrations in blood lymphocytes of testicular cancer patients. I. The effect of vinblastine, cisplatin and bleomycin adjuvant therapy.
Gundy S; Baki M; Bodrogi I; Czeizel A
Oncology; 1990; 47(5):410-4. PubMed ID: 1699190
[TBL] [Abstract][Full Text] [Related]
2. Vinblastine, cisplatin and bleomycin (VPB) adjuvant therapy does not induce dose-dependent damage in human chromosomes.
Gundy S; Baki M; Bodrogi I
Neoplasma; 1989; 36(4):457-64. PubMed ID: 2475796
[TBL] [Abstract][Full Text] [Related]
3. Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin.
Stoter G; Koopman A; Vendrik CP; Struyvenberg A; Sleyfer DT; Willemse PH; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
J Clin Oncol; 1989 Aug; 7(8):1099-104. PubMed ID: 2474060
[TBL] [Abstract][Full Text] [Related]
4. Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine, and bleomycin for disseminated testicular cancer.
van Imhoff GW; Sleijfer DT; Breuning MH; Anders GJ; Mulder NH; Halie MR
Cancer; 1986 Mar; 57(5):984-7. PubMed ID: 2417690
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis.
Johnson E
J Clin Oncol; 1991 Jun; 9(6):1092-4. PubMed ID: 1709684
[No Abstract] [Full Text] [Related]
6. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
[No Abstract] [Full Text] [Related]
7. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of stage I nonseminomatous testicular cancer with one cycle of adjuvant chemotherapy].
Corti Ortíz D; Fonerón Burgos A; Troncoso Schifferli L
Actas Urol Esp; 1997; 21(10):961-3. PubMed ID: 9494159
[TBL] [Abstract][Full Text] [Related]
9. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
[No Abstract] [Full Text] [Related]
10. Late relapse after adjuvant chemotherapy for stage II testicular cancer.
Weiss RB; Natale RB; Sesterhenn IA
N Engl J Med; 1990 Aug; 323(5):350. PubMed ID: 1694968
[No Abstract] [Full Text] [Related]
11. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. 1997.
Einhorn LH; Donohue J
J Urol; 2002 Feb; 167(2 Pt 2):928-32; discussion 933. PubMed ID: 11905920
[No Abstract] [Full Text] [Related]
12. Chromosomal damage in peripheral blood lymphocytes of patients treated for testicular cancer.
van den Berg-de Ruiter E; de Jong B; Mulder NH; te Meerman GJ; Schraffordt Koops H; Sleijfer DT
Hum Genet; 1990 Jan; 84(2):191-4. PubMed ID: 2298456
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative chemotherapy of testicular cancer and Wilm's tumor].
Kawai T
Gan To Kagaku Ryoho; 1985 May; 12(5):1025-30. PubMed ID: 2581512
[TBL] [Abstract][Full Text] [Related]
14. [Spontaneous and cytostatic therapy induced chromosome aberrations in testicular cancer patients].
Gundy S; Baki M; Bodrogi I
Orv Hetil; 1992 Dec; 133(49):3141-6. PubMed ID: 1454357
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
18. Treatment of testicular cancer: a new and improved model.
Einhorn LH
J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic approaches to the treatment of testicular cancer.
Seitz DE; Loehrer PJ; Williams SD; Einhorn LH
Semin Urol; 1988 Aug; 6(3):238-45. PubMed ID: 2469118
[No Abstract] [Full Text] [Related]
20. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
